Ad is loading...
BPTH
Price
$0.81
Change
-$0.09 (-10.00%)
Updated
Nov 15 closing price
VERV
Price
$4.79
Change
-$0.59 (-10.97%)
Updated
Nov 15 closing price
101 days until earnings call
Ad is loading...

BPTH vs VERV

Header iconBPTH vs VERV Comparison
Open Charts BPTH vs VERVBanner chart's image
Bio-Path Holdings
Price$0.81
Change-$0.09 (-10.00%)
Volume$114.34K
CapitalizationN/A
Verve Therapeutics
Price$4.79
Change-$0.59 (-10.97%)
Volume$1.88M
CapitalizationN/A
BPTH vs VERV Comparison Chart
Loading...
BPTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BPTH vs. VERV commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTH is a StrongSell and VERV is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BPTH: $0.81 vs. VERV: $4.79)
Brand notoriety: BPTH and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPTH: 7% vs. VERV: 144%
Market capitalization -- BPTH: $3.01M vs. VERV: $405.54M
BPTH [@Biotechnology] is valued at $3.01M. VERV’s [@Biotechnology] market capitalization is $405.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPTH’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • BPTH’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, VERV is a better buy in the long-term than BPTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPTH’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 6 bullish TA indicator(s).

  • BPTH’s TA Score: 3 bullish, 6 bearish.
  • VERV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than BPTH.

Price Growth

BPTH (@Biotechnology) experienced а -9.12% price change this week, while VERV (@Biotechnology) price change was -24.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BPTH is expected to report earnings on May 16, 2024.

VERV is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($406M) has a higher market cap than BPTH($3.02M). VERV YTD gains are higher at: -65.638 vs. BPTH (-91.226). BPTH has higher annual earnings (EBITDA): -12.88M vs. VERV (-215.68M). VERV has more cash in the bank: 576M vs. BPTH (4.01M). BPTH has less debt than VERV: BPTH (55K) vs VERV (72.5M). VERV has higher revenues than BPTH: VERV (20.6M) vs BPTH (0).
BPTHVERVBPTH / VERV
Capitalization3.02M406M1%
EBITDA-12.88M-215.68M6%
Gain YTD-91.226-65.638139%
P/E RatioN/AN/A-
Revenue020.6M-
Total Cash4.01M576M1%
Total Debt55K72.5M0%
FUNDAMENTALS RATINGS
BPTH: Fundamental Ratings
BPTH
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BPTHVERV
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
BPTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKLB19.001.64
+9.45%
Rocket Lab USA
DEI18.39-0.09
-0.49%
Douglas Emmett
DIN35.30-0.29
-0.81%
Dine Brands Global
YCBD0.49-0.02
-3.83%
cbdMD
GBIO1.54-0.14
-8.33%
Generation Bio Co

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-10.97%
BEAM - VERV
61%
Loosely correlated
-8.59%
EDIT - VERV
55%
Loosely correlated
-3.97%
NTLA - VERV
54%
Loosely correlated
-7.61%
RXRX - VERV
52%
Loosely correlated
-10.64%
PRME - VERV
50%
Loosely correlated
-6.95%
More